NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. HOOD
8. DFTX
9. USO
10. MSFT

Go back to NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment
(NASDAQ: NKGN) Delayed: 0.19 --0 (-0%)
Previous Close $0.19    52 Week High $ 
Open $0.19    52 Week Low $ 
Day High $0.19    P/E N/A 
Day Low $0.19    EPS $ 
Volume 47,866